Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,399 | 50,193 | 117,641 | 87,880 | 67,281 |
| Marketable Securities | 252,903 | 285,884 | 258,162 | 205,047 | 253,040 |
| Receivables | 69,277 | 84,762 | 71,187 | 77,190 | 71,478 |
| Other current assets | 24,298 | 22,552 | 60,384 | 58,610 | 24,985 |
| TOTAL | $479,042 | $550,490 | $507,374 | $428,727 | $416,784 |
| Non-Current Assets | |||||
| PPE Net | 116,344 | 112,549 | 111,865 | 110,223 | 107,077 |
| Investments And Advances | 328,287 | 369,269 | 411,778 | 484,471 | 494,111 |
| Intangibles | 139,230 | 89,871 | 160,335 | 153,115 | 155,064 |
| Other Non-Current Assets | 93,466 | 91,346 | 23,211 | 23,302 | 32,708 |
| TOTAL | $677,327 | $663,035 | $707,189 | $771,111 | $788,960 |
| Total Assets | $1,156,369 | $1,213,525 | $1,214,563 | $1,199,838 | $1,205,744 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 21,125 | 18,654 | 18,088 | 18,887 | 18,238 |
| Accrued Expenses | 34,901 | 34,057 | 23,010 | 21,699 | 16,689 |
| Other current liabilities | 33,626 | 31,780 | 30,852 | 30,273 | 30,512 |
| TOTAL | $90,134 | $84,967 | $72,426 | $71,335 | $65,915 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 15,547 | 15,139 | 14,558 | 11,042 | 11,191 |
| TOTAL | $22,081 | $21,843 | $21,380 | $16,867 | $17,059 |
| Total Liabilities | $112,215 | $106,810 | $93,806 | $88,202 | $82,974 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,401 | 31,231 | 30,912 | 30,609 | 30,444 |
| Common Shares | 4 | 3 | 3 | 3 | 3 |
| Retained earnings | 505,128 | 529,954 | 553,372 | 559,980 | 578,937 |
| Other shareholders' equity | -1,119 | 2,238 | 1,692 | 1,054 | -73 |
| TOTAL | $1,044,154 | $1,106,715 | $1,120,757 | $1,111,636 | $1,122,770 |
| Total Liabilities And Equity | $1,156,369 | $1,213,525 | $1,214,563 | $1,199,838 | $1,205,744 |